BCG shortage for intravesical instillation is associated with early tumoral recurrence in patients with high-risk non-muscle invasive bladder tumours-Reference-Cited by-同舟云学术

BCG shortage for intravesical instillation is associated with early tumoral recurrence in patients with high-risk non-muscle invasive bladder tumours

Published:2023-05 Issue:4 Volume:47 Page:250-258
ISSN:2173-5786
Container-title:Actas Urológicas Españolas (English Edition)
language:en
Short-container-title:Actas Urológicas Españolas (English Edition)

Author:

Pérez-Aizpurua X.,Monzó-Gardiner J.I.,Maqueda-Arellano J.,Buendía-González E.,Cuello-Sánchez L.,Tufet i Jaumot J.J.,Alonso-Román J.,Gómez-Jordana Mañas B.,Ruiz de Castroviejo Blanco J.,Osorio Ospina F.,Cabello Benavente R.,González-Enguita C.

Publisher

Elsevier BV

Subject

General Engineering

Reference26 articles.

1. Predicting recurrence and progression in individual patients with stage Ta T1 Bladder Cancer Using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

2. Validation of the CUETO scoring model for predicting recurrence and progression in T1G3 urothelial carcinoma of the bladder;Krajewski;Actas Urológicas Españolas (English Edition),2019

3. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J Urol,2017

4. Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect;Han;Biomed Pharmacother,2020

5. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study;Lamm;J Urology,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction of hyperglycemia in STZ-induced diabetic mice by prophylactic treatment with heat-killed Mycobacterium aurum: possible effects on glucose utilization, mitochondrial uncoupling, and oxidative stress in liver and skeletal muscle;Frontiers in Endocrinology;2024-09-06

2. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs;Frontiers in Oncology;2023-06-02